Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease.
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
Cholecystocolonic fistula.
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey.
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflamm Bowel Dis. 2020 01 01; 26(1):1-10.
View in:
PubMed
subject areas
Adult
Aged
Colitis, Ulcerative
Cost of Illness
Crohn Disease
Female
Health Care Costs
Health Expenditures
Humans
Inflammatory Bowel Diseases
Longitudinal Studies
Male
Medicare
Middle Aged
Retrospective Studies
United States
authors with profiles
David Rubin